1. Lifestyle genomics and the metabolic syndrome: A review of genetic variants that influence response to diet and exercise interventions.
- Author
-
Fenwick PH, Jeejeebhoy K, Dhaliwal R, Royall D, Brauer P, Tremblay A, Klein D, and Mutch DM
- Subjects
- Apolipoprotein A-V genetics, Apolipoprotein A-V metabolism, Apolipoproteins E genetics, Apolipoproteins E metabolism, Blood Pressure, Body Weight, Dyslipidemias genetics, Dyslipidemias therapy, Health Behavior, Homeostasis, Humans, Insulin Receptor Substrate Proteins genetics, Insulin Receptor Substrate Proteins metabolism, Metabolic Syndrome therapy, Obesity genetics, Obesity therapy, PPAR gamma genetics, PPAR gamma metabolism, Phosphatidylinositol 3-Kinases genetics, Phosphatidylinositol 3-Kinases metabolism, Polymorphism, Single Nucleotide, Randomized Controlled Trials as Topic, Receptor, Melanocortin, Type 4 genetics, Receptor, Melanocortin, Type 4 metabolism, Receptors, Adrenergic, beta-3 genetics, Receptors, Adrenergic, beta-3 metabolism, Transcription Factor 7-Like 2 Protein genetics, Transcription Factor 7-Like 2 Protein metabolism, Diet, Exercise, Genomics, Life Style, Metabolic Syndrome genetics
- Abstract
Metabolic syndrome (MetS) comprises a cluster of risk factors that includes central obesity, dyslipidemia, impaired glucose homeostasis and hypertension. Individuals with MetS have elevated risk of type 2 diabetes and cardiovascular disease; thus placing significant burdens on social and healthcare systems. Lifestyle interventions (comprised of diet, exercise or a combination of both) are routinely recommended as the first line of treatment for MetS. Only a proportion of people respond, and it has been assumed that psychological and social aspects primarily account for these differences. However, the etiology of MetS is multifactorial and stems, in part, on a person's genetic make-up. Numerous single nucleotide polymorphisms (SNPs) are associated with the various components of MetS, and several of these SNPs have been shown to modify a person's response to lifestyle interventions. Consequently, genetic variants can influence the extent to which a person responds to changes in diet and/or exercise. The goal of this review is to highlight SNPs reported to influence the magnitude of change in body weight, dyslipidemia, glucose homeostasis and blood pressure during lifestyle interventions aimed at improving MetS components. Knowledge regarding these genetic variants and their ability to modulate a person's response will provide additional context for improving the effectiveness of personalized lifestyle interventions that aim to reduce the risks associated with MetS.
- Published
- 2019
- Full Text
- View/download PDF